News Conference News AHA 2021 Empagliflozin Retains Benefits in ‘True’ HFpEF Patients Todd Neale November 17, 2021
News Conference News AHA 2021 AVATAR Supports Early SAVR in Asymptomatic Severe AS Patients L.A. McKeown November 13, 2021